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Caloric restriction and the nutrient-sensing protein kinase TOR1 alter the pattern of 
protein phosphorylation in quiescent and non-quiescent cells of Saccharomyces cerevisiae 
 
Darya Mitrofanova, M.Sc. 
 
The application of yeast as a model organism for studying eukaryotic pathways, notably 
mechanisms and processes of chronological aging, has been recognized for decades. In fact, 
several signalling pathways of longevity regulation are conserved across phyla; humans (and 
other mammals) have orthologs and homologs of yeast proteins integrated into these pathways. 
One of such pathways is the TOR pathway that responds to nutrient levels, notably via TORC1 
(a complex with protein kinase activity; contains TOR1 as a core protein). My thesis taps into 
both of those advantageous properties of Saccharomyces cerevisiae: its ease of culturing for 
chronological aging studies, and well annotated proteome. I study the chronologically aging 
quiescent and non-quiescent cell populations under caloric restriction or not using wild-type or 
tor1 single gene deletion mutant strains. I use quantitative phosphoproteomics – by means of 
mass spectrometry – to assess the differences and similarities between different cell populations. 
Caloric restriction has previously been shown to extend the chronological lifespan of yeast and 
other organisms. Reduced TOR1 activity (such as via inhibitors or by gene deletion) is also 
shown to extend yeast chronological lifespan in literature. Quiescence, an ability of a nutrient-
limited post-mitotic cell to re-enter the cell cycle when the nutrient supply is restored, is also a 
lifespan-extending process. Combining these factors, I compared the phosphoproteomes of 
quiescent and non-quiescent yeast cells limited or not limited in calorie supply and having or 
lacking the TOR1 protein. I found that both the diet and the state of quiescence have significant 
effect on the phosphorylation of proteins. Moreover, I found that a single-gene-deletion mutation 
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CHAPTER I: INTRODUCTION 
1: Saccharomyces cerevisiae 
1.1: Model organism 
Among the many advantages of using Saccharomyces cerevisiae (S. cerevisiae) is the 
availability of its mutant library created in 1998-2002 (Giaever and Nislow, 2014). My research 
takes advantage of all the features that make yeast an ideal model organism: 1) short 
chronological lifespan (which does not exceed several weeks for wild-type cells cultured in a 
nutrient-rich medium), 2) known ways to extend chronological lifespan (such as dietary caloric 
restriction, certain mutations, exogenous additives like lithocholic acid and some anti-aging plant 
extracts), 3) easy to study chronological lifespan, 4) availability of mutants (particularly the 
TOR1 deletion mutant), 5) evolutionarily conserved signalling pathways (invoking potential 
medical relevance), and 6) a multifaceted body of knowledge from the full genome sequence to 
cell-to-cell interaction of this unicellular eukaryote. Furthermore, S. cerevisiae, like the other 
yeast model organism Schizosaccharomyces pombe, can proliferate in a haploid state thereby 
making mutant studies much easier. In fact, the MATα strain used in my experiment is haploid. 
Therefore, haploid gene-deletion mutants are absolute knockouts, and no sexual reproduction can 
occur in the absence of a Mata yeast strain in the culture. Nonetheless, diploid forms are also of 
interest since most metazoan cells are diploid thus allowing yeast to be a model for 
recombination studies. 
My thesis is based on chronologically long-lived cell population of quiescent yeast cells. There 
are two main factors that allowed me to work on chronologically long-lived cells: dietary caloric 
restriction (CR, versus non-caloric restriction, non-CR) and quiescent (Q, versus non-quiescent, 
NQ) cell populations of yeast. In the following chapters, I will address the importance of these 
factors.  
 
1.2: S. cerevisiae aging 
The two known modes of aging in Saccharomyces cerevisiae are replicative aging and 
chronological aging. These modes of aging are applicable to aging of cells derived from other 
eukaryotic organisms, which brings forth the relevance of yeast as a model organism for 
studying aging.  
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The replicative mode of aging is defined by the number of daughter cells (buds) a mother cell 
can produce before becoming a senescent (i.e. becoming incapable to divide). In yeast, it is 
relatively easy to quantify the replicative age of a given cell by using a microscope to count the 
number of bud scars (which mark the places of daughter cell separation) on the surface of the 
mother cell. The chronological mode of aging is arguably the type of aging the public thinks of 
when aging is mentioned. Chronological aging quantifies the length of time a given cell is able to 
survive under favourable (normal) conditions; similar to a multicellular organism living la vida 
loca. The nuance is that the chronological aging of a cell is monitored after the cell becomes 
mitotically inactive. These two modes of aging can be proxies for aging of different types of 
cells in multicellular organisms. The replicative lifespan (RLS) is alike aging in mitotically 
active cells of metazoans (such as cells in the self-renewing tissues of skin and liver). The 
chronological lifespan is alike aging of mitotically inactive cell populations (such as neurons, but 
unlike immune stem cells). 
Due to its relevance in self-renewing tissues, replicative life span is extensively studied. In fact, 
RLS has been studied using genetic, lipidomic, metabolomic, and proteomic approaches. Many 
of the discoveries in yeast found their application in other eukaryotic model organisms, including 
human health and cancer research. Because both RLS and CLS are inevitably tied to major 
cellular events like regulation of cell cycle transitions, programmed cell death, and nutrient 
processing, the regulatory networks of these modes of aging partially (but not completely) 
overlap. Both RLS and CLS are under control of the same set of signaling pathways. Of interest 
are the Sch9 and protein kinase A (PKA) pathways, both of which are integrated into a network 
that includes the TOR pathway (Powers RW 3
rd
 et al, 2006).  
From individual experiments and cross-sectional studies emerge patterns of a bigger picture. 
Yeast is often at the core and root of such branching studies applicable to many fields. For 
example, S. cerevisiae contributed to the characterization and subsequent understanding of 
eukaryotic aging through such approaches as genetics, proteomics, lipidomics, and 
metabolomics. This allowed for formulations and updates of working models of normal aging in 






1.3: Hallmarks of aging 
Several hallmarks of aging have been described in literature (López-Otín et al, 2013). These 
include primary, antagonistic, and integrative hallmarks (López-Otín et al, 2013). Primary 
hallmarks are causes of damage – and aging is the accumulation of damage (López-Otín et al, 
2013). Antagonistic hallmarks arise as a response to the damage and initially, in small doses, 
have a protective/positive effect; yet, when such responses are overstimulated, they cause harm 
and thus promote aging (López-Otín et al, 2013). Integrative hallmarks arise when primary and 
antagonistic hallmarks damage the tissue beyond the repair mechanisms of a particular tissue 
(López-Otín et al, 2013). Primary hallmarks include genomic instability (affecting nuclear and 
mitochondrial DNA integrity, and nuclear lamina stability), telomere attrition (most relevant in 
mammals), epigenetic alterations (chromatin and DNA state and aberrant transcription and 
transcription products, with arguably leading roles of sirtuins genes), and loss of proteostasis 
(López-Otín et al, 2013). The latest is of particular interest to my phosphoproteomics research 
notably due to target of rapamycin (TOR) system involvement in longevity. Antagonistic 
hallmarks include deregulation of nutrient-sensing systems (where TOR often plays a role, as 
well as AMPK, sirtuins, and the insulin and IGF-1 signaling pathway in multicellular model 
organisms), mitochondrial dysfunction (with consideration of ROS and sirtuins genes), and 
cellular senescence (in this context argued as an initially protective process ridding the organism 
of damaged cells) (López-Otín et al, 2013). The integrative hallmarks are relevant to 
multicellular organisms and include stem cell exhaustion and alterations of intercellular 
communication (López-Otín et al, 2013). All the hallmarks are arguably observed in normal 
aging cells/organisms, accelerate aging if exaggerated, and increase healthspan/lifespan of 
normal aging cells if abolished (López-Otín et al, 2013). 
 
1.4: Quiescence 
In the context of yeast cells, quiescent cells are the cells arrested at G1, and surviving in G0. 
Several facets need to be taken in consideration. For one, there are certain triggers that will coax 
the yeast population to differentiate into quiescent (Q) and non-quiescent (NQ) 
subpopulations/populations (in this report called populations). Such triggers include exhaustion 
of dietary glucose; notably, caloric restriction (CR) without malnutrition. For two, the conditions 
under which the culture has grown previously have an effect on the timing of the exit from G1 
4 
 
(Mohammad and Titorenko, 2018). In fact, under non-CR conditions, cells enter quiescence at 
late G1 (failure to go through with checkpoint START A) (Mohammad and Titorenko, 2018). 
Under CR, cells enter quiescence at early G1 (Mohammad and Titorenko, 2018). For three, when 
the cells initially enter G0, they are not differentiated and are high density (in Percoll density 
gradient) (Leonov et al, 2017).  
Previous research in our lab has described several characteristics of quiescent yeast cells 
(Leonov et al, 2017). The Q cells are characterized by increased reproductive competence, 
increased glycogen, trehalose, and cardiolipin concentrations, decreased triacylglycerol 
concentration, decreased reactive oxygen species (ROS) concentration and oxidative molecular 
damage, increased mitochondrial functionality, increased thermal and oxidative stress 
resistances, and decreased susceptibilities to apoptotic and liponecrotic regulated cell deaths 
(RCDs) (Leonov et al, 2017). Also, other properties have been described, such as: lower 
expression rates, translation from internal initiation sites, gene repression, inhibition of mRNA 
degradation, lower protein synthesis rate, chromosome condensation, and thicker cells walls 
(Gray et al, 2004, and references within). Such properties have been described previously in 
literature (Allen et al, 2006). Other important features of quiescent cell population are 
reproductive competence and ability to synchronously re-enter the mitotic life cycle (Leonov et 
al, 2017).  
There are also physical properties that ensue from the physiological properties tying quiescence 
and caloric restriction. Quiescent cell population under CR are smaller than under non-CR while 
NQ cell population have similar sizes under both diets (Leonov et al, 2017). Additionally, Q 
cells are predominantly unbudded under both CR and non-CR conditions, in contrast with NQ 
population consisting of both budded and unbudded cells (Leonov et al, 2017). Both Q and NQ 
have a lesser proportion of budded cells under CR (Leonov et al, 2017). 
The above-described properties of quiescent cells have been tied to the mechanisms/programs to 
delay of chronological aging. In fact, quiescence contributes to delay of chronological aging 
(Leonov et al, 2017). As such, it is relevant to describe the several stages tied to quiescence: 
entry into quiescence (exit from the G1 proliferative phase), maintenance of quiescence 
(metabolically active survival in G0), and entry into non-quiescence (committed from 
quiescence) (Leonov et al, 2017). These processes are dependent on several conditions such as 
the growth medium, as mentioned previously with the entry into quiescence being dependent on 
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the growth medium being CR or non-CR. In fact, the caloric content plays a big role in all three 
processes. The first, as previously mentioned, is the how early (under CR) or late (under non-
CR) the population enters quiescence (Mohammad and Titorenko, 2018). The second is the 
prolonging of quiescent state maintenance under CR (Leonov et al, 2017). The third is the entry 
into NQ: the cells will commit to differentiation from Q to NQ (the terminal state leading to cell 
death) later under CR as opposed to under non-CR (Mohammad and Titorenko, 2018). From the 
above ensues that the quiescence state is not terminal. In fact, cells can exit quiescence and, thus, 
enter NQ state (Mohammad and Titorenko, 2018).  
Historically, quiescent cells have been assumed to be the majority of the cells at stationary phase 
(ST) (Gray et al, 2004). In fact, here is a reminder about the relationship between the culture 
state and cell state grown in rich medium (such as YEPD). When the carbon source, such as 
glucose, is available the cells will proliferate quickly and thus the culture grows logarithmically 
(log phase, L). Upon significant drop in glucose availability, a diauxic shift (D) occurs, marking 
dramatic changes in the metabolic behavior of cells due to thorough rearrangement of its 
expression, proteome, metabolome, and lipidome. The culture then transitions into the post-
diauxic phase (PD), in which cells proliferation is slowed down considerably compared to their 
log phase. At last, when the dietary glucose (carbon source) is depleted, the culture enters the 
stationary phase (ST), with many/most of its cells existing in a non-proliferative state termed 
quiescence (Gray et al, 2004). As such, quiescent cells form a population when glucose is 
depleted from the medium (at ST). Nevertheless, there are quiescent cells as early as during 
logarithmic stage (Leonov et al, 2017). 
It is worth mentioning that entry into quiescence state seems to be inhibited by the protein kinase 
A (PKA) and by target of rapamycin (TOR) pathways under conditions of abundant/sufficient 
nutrients (including carbon content; in my experiments controlled by levels of glucose in growth 
medium). Therefore, upon diminished (but not depleted) nutrient levels, the nutrient-sensing 
TOR pathway is suppressed, causing the post-diauxic shift (PD). Then, upon complete glucose 
exhaustion, the TOR pathway is fully suppressed and therefore no longer suppresses the entry 
into quiescence. The PKA pathway responds in the same manner – in this context – to nutrient 
(glucose) depletion. Thus, upon glucose exhaustion (stationary phase), both TOR and PKA 
pathways are inhibited from inhibiting entry into quiescence. More details about the TOR and 
PKA pathways in the following sections. Also worth consideration are cells deficient in TOR. 
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These cells cannot suppress entry into quiescence via the TOR pathway regardless of the nutrient 
levels, but the PKA pathway can still inhibit entry into quiescence under high nutrient condition.  
 
1.5: Dietary caloric restriction 
The benefits of dietary caloric restriction without malnutrition have been noted in many 
organisms. In fact, humans have been adamant about intermittent fasting for centuries. With 
humans, however, it is a challenge to make sure the individual under fasting is not malnourished 
given their lifestyle and current health. In yeast, however, it is much easier to insure a caloric 
restriction regime since the organisms are unicellular, mostly homogeneous in behaviour in 
culture, and have well studied nutritional demands. While researchers sometimes focus on 
studying mutants to identify the shortening of the lifespan, it is easier to study the prolonging of 
lifespan. In fact, if a mutant causes a shortened lifespan (be it RLS or CLS), it may not be a 
direct agent but rather a general deregulating factor leading to random cell death (Kaeberlein and 
Kennedy, 2005). Since CR effects of both RLS and CLS have been noted, researchers naturally 
began investigating the mechanisms of action behind this intervention. 
Notably, the success of caloric restriction in CLS extension is achieved through dampening of 
the TOR pathway (Power RW 3rd et al, 2006). In the work by Power III et al, the research group 
screened yeast mutants for extended CLS, and found that several mutants of reduced TOR 
pathway signalling, and inhibition of TOR signalling by exogenous manipulations (amino acids 
depletion or TOR-inhibiting drug administration) all lead to an increase in CLS (Power RW 3rd 
et al, 2006). 
 
1.6: Target of Rapamycin (TOR) 
The TOR (target of rapamycin) pathway is one of the highly conserved pathways across 
eukaryotes. The TOR pathway is of interest from two major aspects: scientific curiosity and 
human health. In fact, aberrations of the TOR pathway lead to severe cellular and organismal 
issues. This includes tuberous sclerosis (hyperactive mTORC1 due to defective upstream 
regulators TSC1/2 leads to tumours) (Kim et al, 2017). In fact, active mTORC1 – that is under 
high nutrient conditions – positively affects two major cellular processes (which are incidentally 
crucial for phosphoproteomics): ribosome biogenesis and protein synthesis (Humphrey et al, 
2015). Therefore, massive upregulation can favour tumour growth by allowing the cell 
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accumulation of proteins while also denying programmed cell death pathways. Indeed, mTORC1 
indirectly inhibits initiation of programmed cell death through apoptosis.  
 
1.6.1. Rapamycin 
The TOR1 and TOR2 genes were found as yeast mutants resistant to rapamycin (and henceforth 
called target of rapamycin) in 1991 (Heitman et al, 1991). In S. cerevisiae, only TOR1 (but not 
TOR2) mutants are fully rapamycin-resistant (Heitman et al, 1991). Later, TOR1 and TOR2 
proteins were found to be paralogs from genome duplication. Treatment of cells with the 
antibiotic rapamycin (or rapamycin-like compounds) leads to cell growth defects through low 
protein and ribosomal synthesis, incompetent accumulation of nutrient-storage compounds (such 
as glycogen and glycerol) required for long-term survival, as well as spacio-temporal 
developmental issues in multicellular organism. Rapamycin indirectly inhibits translation 
initiation by directly inhibiting receptor at the cell surface therefore preventing TOR1 association 
with Raptor (KOG1) and LST8 into TORC1 protein complex. Rapamycin binds to FKBP12 
(FK506-binding protein 12) forming FKBP12-rapamycin complex that inhibits TOR (Raught et 
al, 2001) (TOR1 but not TOR2 in yeast) activity. In a heterozygous cell, a heterozygous 
mutation of FKBP (one mutant allele, one WT allele) one WT copy of FKBP is sufficient to bind 
to rapamycin and irreversibly bind to TOR thereby inhibiting TOR. A heterozygous mutation in 
TOR that cannot bind FKBP-rapamycin complex is sufficient to avoid inhibition by rapamycin 
(Florian et al, 2007). TORC2, unlike TORC1, is not sensitive to rapamycin treatment 
(Wullschleger et al, 2006). 
Notably, the TOR pathway refers to two core protein complexes, TORC1 and TORC2. Both 
TOR1 and TOR2 proteins are part of the protein complexes TORC1 and TORC2 – TOR1 
participates in TORC1 only, while TORC2 participates in both complexes. When referring to the 
TOR pathway in the context of dietary calorie restriction it is of relevance to consider the 
TORC1 protein complex as it is nutrient-sensing, whereas TORC2 is cell cycle dependant. 
TORC1 and TORC2 complexes in yeast have overlapping functions (Florian et al, 2007).  
In S. cerevisiae, there are two highly similar TOR proteins (coded by TOR1 and TOR2 genes). 
These proteins may be referred to as mechanistic target of rapamycin (mTOR) because of the 
identified counterparts in metazoans. Only one copy of TOR protein has been identified in 
metazoans (Raught et al, 2001). In mammals, the TOR protein, mTOR, has shared identity to 
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both TOR1 and TOR2; mammalian TOR is also called FRAP, FRAP1, FRAP2, RAFT1, RAPT1 
(UNIPROT/P42345). Caenorhabditis elegans worms have CeTOR (alias target of rapamycin 
homolog, lethal protein 363) (UNIPROT/Q95Q95). In drosophila, there is TOR with more 
shared identity with TOR2 than with TOR1. Please note that mTOR is also often referred to as 
mammalian TOR, in the context of mammals (often: humans). Therefore, referring to mTOR in 
the context of yeast does not imply that yeast have mammalian TOR yet implies that yeast 
mTOR (TOR1 and/or TOR2) acts identically to mTOR in mammals, worms, and flies. The 
mTOR is a kinase phosphorylating its targets such as SCH9 (yeast; S6 kinase-1 (S6K) in 
mammals and flies; RSK-1 in worms). Phosphorylated S6K can phosphorylate ribosomal S6 
protein, eIF4B (thus allowing eIFB association with eIF4A) and PDCD4 (not found in yeast; 
inhibitor of eIF4A) thus leading to acceleration of translation (via mRNA leaders unwinding 
promoting ribosomal binding) (Weaver p549-551). The protein eIF4A is also regulated by Snf1 
(sucrose non-fermenting protein 1); Snf1 is active upon glucose exhaustion, maintaining 
homeostasis and cell growth.  
 
1.6.2. Upstream of TOR: AMPK 
TOR being part of a nutrient-sensing signaling pathway has not only the ability to respond to 
intracellular nutrient/energy levels, but also to affect downstream proteins leading to changes in 
the cell functioning. Under high nutrient conditions (such as while yeast are grown in nutrient-
rich medium and glucose is abundant), TOR can phosphorylate its targets (such as SCH9 in 
yeast). Conversely, under low nutrients, TOR is inactive. The inverse is true for AMPK (AMP-
activated protein kinase) an upstream regulator of TOR. Under high nutrients (high ATP – low 
AMP – high energy), AMPK is inactive. Under low nutrient (high AMP – low energy), AMPK is 
activated and can inhibit TORC1 (via TOR). Tying this to dietary caloric restriction: under CR, 
TOR is inactive and is inhibited by active AMPK. Some interventions, such as treatment with 
metformin (in worms and mice) mimic the benefits of caloric restriction because metformin 
activates AMPK (López-Otín et al, 2013). In sum, high nutrient conditions allow TOR to 
promote anabolism and normal cell function, while low nutrient conditions inhibit TOR, and 





1.6.3. Downstream of TOR: Sch9  
Another important protein tying nutrient-sensing and aging is SCH9 (a Ser/Thr protein kinase). 
Like other core signalling proteins, SCH9 has homology with other eukaryotes (SGK-1, AKT-2, 
and AKT-1 in C. elegans; S6K in mammals). The Sch9 protein is activated by phosphorylation 
by TORC1, and can then inhibit RIM15 which is an agent in cell cycle arrest favoring 
quiescence. Active SCH9 suppresses stress response genes transcription while promoting 
ribosomal biogenesis (Leonov et al, 2017) (a feature commonly attributed to TOR).  
In addition to TORC1 (yeast), there are 3 more core proteins required for adequate response of 
the cell to nutrient depletion: PKA (protein kinase A), Snf 1 (sucrose non-fermenting, protein 1), 
and Pho85 (phosphate metabolism, protein 85) (Leonov et al, 2017). In tandem or in exclusivity, 
these proteins regulate such downstream effector proteins as: Rim15, Sch9 (as discussed above), 
Yak1, Mck1, Msn2/4 and Gis1, Hsf1, Gln3, Gsy2, Atg1-Atg13 complex, Sfp1, eIF2α, Crz1, Igo1 
and Igo2 (paralogs), ad Mpk1 (Leonov et al, 2017). These cores – TORC1, PKA, Snf1, and 
Pho85 – are also required for cell cycle arrest (at G1), subsequent differentiation into Q/NQ 




The field of phosphoproteomics is the study of post-translational modification of 
phosphorylation of proteins. Such phosphorylation is most often carried out by a protein kinase, 
which adds a phosphate (PO4) group to a polar group of an amino acid. Hence, the 
apolar/hydrophobic amino acid becomes polar/hydrophilic (Ardito et al, 2017). Posttranslational 
phosphorylation is a reversible modification. While the addition is mediated by protein kinases, 
the dephosphorylation is usually executed by protein phosphatases. The kinases can 
phosphorylate the hydroxyl (OH) group of an amino acid (such as serine, threonine, and 
tyrosine) acting as phosphoryltransferases, generally sourcing the phosphate group from the 
ultimate biological phosphate donor: adenosine triphosphate (ATP). The phosphatases remove 
the phosphate, but do not perform directly the reverse reaction, in terms of chemistry. The 
phosphatases hydrolyze at the phosphoric acid monoesther (Ardito et al, 2017) (R-O-PO3 +H2O 
 R-OH + PO4 where R is an amino acid) site restoring the OH group of the amino acid. In the 
rare event of phosphorylation of aspartate (such as in threonine biosynthesis pathway in yeast 
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(Yeast pathways, 2007)), the phosphate group addition occurs at the carboxylic acid. Another 
rare event is phosphorylation of histidine on its imidazole ring.  
 
2.2: Kinases 
There are several types of protein kinases (henceforth called kinases) and protein phosphatases 
(henceforth called phosphatases) generally classified by their substrates. For kinases, the 
classification is by the phosphorylated amino acid. Most known kinases are serine/threonine 
kinases (STKs) (Ardito et al, 2017). Serine is most prevalent phosphosite (Psite), with an 
estimate of about 86% Psites being on serine while threonine Psites are estimated at about 12% 
(Ardito et al, 2017). A lesser proportion are tyrosine kinases (TKs); tyrosine Psites constituting 
about 2% (Ardito et al, 2017). The smallest portion is serine/threonine/tyrosine kinases (dual-
specificity kinases; DSKs) which can also phosphorylate STKs and TKs (Ardito et al, 2017). 
Protein kinases may have discrete or overlapping sets of substrates effectively allowing many 
kinases to phosphorylate several sites on a given protein (Humphrey et al, 2015). 
 
2.3: Phosphatases 
Phosphatases are also classified by their specificity. Unsurprisingly, the most important are 
phosphatases that can dephosphorylate the most abundant Psites (phosphoserine/pSer, 
phosphothreonine/pThr, and phosphotyrosine/pTyr). The two described families are 
phosphoprotein phosphatases (PPPs) and metallo-dependent protein phosphatases (PPMs) 
(Ardito et al, 2017). Notably, the metal dependency is mostly a regulatory method as the metal 
(often magnesium/Mg
2+
) binds ATP to allow the above-described phosphate transfer. Another 
family of phosphatases are protein-tyrosine phosphatases (PTPs). These generally have higher 
selectivity for pTyr than do PPPs and PPMs, but are not exclusive to pTyr dephosphorylation, 
and even operate non-protein targets (Ardito et al, 2017).  
 
2.4: Roles of phosphorylation 
On the molecular level, protein phosphorylation is a critical modification playing several roles in 
the functioning of the cell, as reviewed by Ardito et al (Ardito et al, 2017). One of the functions 
of phosphorylation is to activate/deactivate a protein target (Ardito et al, 2017). The simplest 
model would be a protein that depends on only one Psite and is either turned on upon being 
11 
 
phosphorylated (inactivated upon dephosphorylation) or turned off upon phosphorylation 
(activated upon dephosphorylation). In reality, most proteins are likely under the control of 
several Psites and multiple kinases at once. A prominent reason for the change in the activity of 
the target is a change it its conformation (Humphrey et al, 2015). A second function of 
phosphorylation is to allow for protein-protein interactions which are generally temporary yet 
crucial in signal transduction (Humphrey et al, 2015; Ardito et al, 2017). A third function is 
inducing subcellular translocation of the target (Humphrey et al, 2015; Ardito et al, 2017). The 
forth utility is influencing other PTMs that rely of the phosphorylation state (Humphrey et al, 
2015; Ardito et al, 2017). A fifth role plays out in the production/recycling of ATP (Ardito et al, 
2017) – a crucial role for it is in the phosphate groups that ATP holds its power. Phosphorylation 
may also play roles in the turnover of the protein (Humphrey et al, 2015). 
 
2.5: Approaches 
To answer questions on phosphorylation, one can use in vivo, in vitro and/or in silico approaches. 
The lively in vivo approach is straightforward: isolate and study the phosphosites under given 
conditions. While the techniques, software, and machines to allow this are relatively new, the 
idea is not. In fact, phosphorylation events had been studied by radiolabeling for over half a 
century using 
32
P. While this approach was valuable in detecting phosphorylation state, it did not 
yet inform the researchers about which amino acids were phosphorylated (coupling radiolabeled 
proteins to restriction enzymes did to some extent) until these samples were input to a mass 
spectrometer. With the advances of mass spectrometry, precise Psite mapping became possible, 
first using different labelling techniques and now label-free. Similarly, in vitro studies are a 
staple for proteomics (notably in protein-protein interactions). Rather than treating whole cell 
populations, a protein mixture can be incubated with protein kinase(s) of interest and analysis 
performed as in vivo be it radiolabeling or MS. The in vitro approach is not the better to use in 
the context of studying the active phosphoproteome of the cells, since kinases and phosphatases 
in a live environment do not necessarily operate (active/inactive, rates, competition, etc) as in an 
artificial environment. However, the in vitro studies are useful in finding potential phosphosites. 
Similarly, the experiment can be designed as a flow-through with either a fixed target (protein of 
interest) with all known kinases flown over or with fixed kinase with proteins flown over – both 
experiments seeking to establish potential protein interactions. A narrower biochemical approach 
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can be used to study the speed of reactions in a given pathway, for example, to determine which 
reactions take precedence under given conditions. While such kinetics studies add depth to given 
pathways, they are not contributing much to the overall understanding of the phosphoproteomes. 
A trend, however, emerged; kinase and phosphatases enzyme activity assays have shown that 
phosphatases generally execute their function faster than do kinases. This makes phosphatases a 
particular threat for proteomic samples.  
The modern toolkit to study phosphorylation events also includes immune-targeting. With 
immunodetection, the costly issue is access to antibodies. While some antibodies may have a 
wider range of binding (for example to the common phosphosites pSer, pThr, and pTyr (Thermo 
Fisher Scientific)), most have much narrower specificity to benefit isolation of target proteins. 
The antibodies can be used in Western blots, immune-precipitation, immune-histochemistry, 
ELISA (enzyme-linked immunosorbent assay), flow cytometry, and microarrays (Thermo Fisher 
Scientific). While this approach facilitates studies of proteins of interest, it is arguably not the 
best to study entirety of the phosphoproteome. 
Like many aspects of molecular biology today, the phosphoproteome is digitalized (as discussed 
below) and thus available for in silico studies. Both in vivo and in vitro studies contribute to the 
current knowledge of the phosphoproteomes and thus make computer-learning possible. Notably, 
many predictions about protein interactions (including kinase-target events) can be made using 
software that compares compatibility between enzyme binding site(s) and potential target. These 
softwares are made possible by the improvement of bioinformatics. Bioinformatics also greatly 
developed the data processing. 
 
2.6: Phosphoproteomes 
Studying post-translational phosphorylation events gives insight to the state of the protein 
detected as well as its upstream regulators (protein kinase(s) and/or protein phosphatase(s)). For 
most phosphorylation sites generated by MS, there is no known kinase responsible. Moreover, 
many (arguably, most) P-sites are described in large numbers (with high confidence). 
Computations also predict that a large portion of the kinome (for any organism) is unknown 
(Needham et al, 2019). 
To represent the gigantic datasets of phosphoproteomics, there are several approaches. A 
sensible start is to consider uploading the obtained datasets online to contribute to the global 
13 
 
discovery of phosphosites. In fact, websites such as phoshopep.org, phosphosite.org, 
phospho.elm.eu.org and networkin.info aim to accumulate phosphosite data (from S. cerevisiae, 
C. elegans, D. melanogaster, bacterial, and mammals/human studies) and on other PTM. A lot of 
information is shared and cross-referenced among these websites, and a great portion is manually 
curated. So these databases are not yet fully automated (in my opinion it is largely because there 
is no agreement in the proteomics community on how to share findings and how much to share 
without losing ownership of discoveries) but nonetheless provide practical guidance. One of such 
useful applications is the prediction of phosphosites and associated kinases. For my experiment, 
for example, I can compare the predicted phosphosites versus the obtained phosphosites. A 
major difficulty, however, is that the MS methods (and the sample preparation, such as the 
phosphopeptide enrichment) are different enough to make comparisons too ambiguous in their 
conclusions. As such, methods of data acquisition must be considered when comparing datasets 
yet the acquisition method is not always obvious when working with the above-mentioned 
websites. Nonetheless, there are also trusted websites that classify and orchestrate massive 
databases in a generally accepted way. These giants include UniProt (UniProtKB/Swiss-Prot that 
is manually curated and is reviewed and UniProtKB/TrEMBL that is unreviewed, automatically 
curated data both at uniprot.org), ExPASy (at expasy.org), Protein Data Bank (PDB at rcsb.org), 
and the National Center for Biotechnology Information (at ncbi.nlm.nih.gov/protein). The above 
websites are all free to access within the scientific community. There are paid softwares that task 
in predicting phosphorylation sites – among other features – but these most commonly rely on 
one or more of the aforementioned databases giants. 
Having accumulated the lists of phosphosites on respective proteins, there must be biologically 
significant conclusions (or new hypotheses) drawn. For such purposes, the data can be viewed in 
several ways. One method is to classify the proteins by the biological and/or molecular function. 
In such presentation, suggestions can be made about the general state of the source cells. I 
present such data. Another way is to focus on a subset of protein of interest. For example, to 
focus on proteins already known or suggested to be involved in a pathway/process of interest. 
Such studies can lead to more honed and narrowed one-protein studies involving the isolation of 
said protein under given conditions and subsequent in vivo assays to describe novel features. 
That is not a path I have chosen for my masters project, although I do look at several proteins of 
interest. As with general proteomics, expression patterns can also be quantified. In fact, keeping 
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the same methods, I can compare relative protein abundance across samples. Having the relative 
abundance of certain key proteins of known pathways of interest, I can suggest the activity state 
of the given pathway in different cell populations. A more dynamic approach is to visualize the 
phosphoproteome as a network of nodes and branches, such as using Cytoscape (free software 
download available at cytoscape.org), with annotations about the PTM state. A more advanced 
method has been developed in which many more factors are integrated including interactive 
protein description and animations called the Minardo plot (a stunning example available at 
https://minardo.org/snapshots/mitosis for the phosphoregulation of mitosis). 
 
3: Mass Spectrometry 
The crown of my experiment is the use of mass spectrometry to study the phosphosites. Mass 
spectrometry has seen a lot of improvement in sensitivity, precision, accuracy, and depth of data 
acquisition; phosphoproteomics has tremendously benefited from this advancement. Higher 
sensitivity of MS instrument allows for smaller sample sizes since lower abundance molecules 
can be detected. Sample preparations methods are also central to proper analysis by mass 
spectrometry. The improvement in procedures allowed for detection of very low abundance 
proteins (Humphrey et al, 2015). That is a notable advantage in processing scarce samples such 
as patient tissues.  
 
3.1: Phosphopeptide enrichment 
To study the phosphoproteomes, samples should be phosphoenriched. In fact, processing non-
enriched samples (i.e. peptides forming the entire proteome) yields much lower detection of 
Psites than enriched samples (i.e. primarily peptides with a phosphorylation event). Effectively, 
samples with potentially low abundance of phosphopeptides give in better to analysis when 
concentrated. The method used to concentrate phosphopeptides is metal oxide affinity 
chromatography (MOAC) using titanium dioxide (TiO2) magnetic beads. Other metal oxide 
beads suitable for MOAC include zirconium dioxide (ZrO2) and magnetite (Fe3O4) (Riley and 
Coon, 2016). The limitation of such approach is in the TiO2 beads as they have a high affinity for 
pSer, pThr, and pTyr. As such, this methods aids in the detection of the most common PTM 
phosphosites. It is up to some debate in the literature as to the gravity of omitting to focus on the 
proteins with the instable phosphor-histidine and phosphor-aspartate. The consensus is that 
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obtaining high-quality data on a large number of stable Psites is valuable and unstable Psites 
require a different sample preparation.  
An alternative enrichment method is using immobilized metal affinity chromatography (IMAC). 
Similar to MOAC, IMAC has a bias towards pSer, pThr, and pTyr (Thermo Fisher Scientific). 




-IMAC – to bind the 
phosphorylated peptide (Riley and Coon, 2016; Thermo Fisher Scientific). The metal is chelated 
(as in MOAC) to be immobilized (hence, the name IMAC) on magnetic beads (like in MOAC) 
or on silica-based resins (Riley and Coon, 2016). The difference between MOAC and IMAC is 
in the chelated metals used – metal oxides in MOAC and metal cations in IMAC – rather than 
immobility/mobility as the IMAC name might suggest.  It is argued that to obtain the optimal 
coverage of the phosphoproteome, a combination of IMAC and MOAC techniques may be 
needed (Riley and Coon, 2016). 
 
3.2: Chosen MS methods 
My research is a bottom-up proteomics approach to studying the phosphoproteomes. Typically, 
bottom-up proteomics uses a protease (in my study: trypsin) followed by MS analysis. The top-
down approach would avoid proteases. In fact, top-down approach is focused on identifying the 
structure of the protein(s), which would be annihilated by proteolytic digestion. Bottom-up 
studies, however, identify the proteome. Notably, bottom-up approach is also referred to as 
shotgun (HPLC-MS). 
Trypsin is a protease with high specificity cleaving at the C-terminus of lysine and arginine 
(Riley and Coon, 2016). Since the produced peptides are also suitable for MS analysis, trypsin is 
the most used protease in proteomics (Riley and Coon, 2016). 
The chosen approach to compare samples was label-free. As the name suggests, there is no 
labeling introduced to my samples (radioactive, fluorescent, or otherwise). This meant that for 
analysis, each sample was run separately since there is no distinguishing feature (alias label) to 
indicate the origin or the sample.  
Another feature of the protocol is liquid chromatography followed by tandem mass spectrometry 




There are two main ways to obtain data from mass spectrometric fragmentation: data-dependent 
acquisition mass spectrometry (DDA-MS) and data-independent acquisition MS (DIA-MS). As 
their names suggest, the difference lies in how the machine selects precursor ions for further 
fragmentation. In DDA, the machine relies on the freshly-generated spectra, in real time, before 
continuing. In DIA, the fragmentation is predefined by the researcher at a fixed m/z ratio. In the 
context of studying PTM, both DDA and DIA could be advantageous because the m/z of the 
functional group (example: phosphate group for phosphoproteomics) is know and can be 
incorporated into the workflows. The chosen mass spectrometry approach relied on data-
dependant acquisition. This means that each fragmentation event was chosen based on the 
previous spectrum (previous fragmentation event result). Effectively, the sample peptide is 
ionized at the source (nano-electro-spray) generating the precursor ions. Their detection is mass 
spectrum 1 (MS1). The nine most abundant multiply-charged ions among each MS1 are chosen 
for collision-induced dissociation (CID) with dynamic exclusion. The generated ions are 
detected, generating MS2. If the fragmentation of the precursor ion caused the neutral loss of a 
phosphate group, another round of CID (with multistage activation) is induced. The resulting 
detected ions generate MS3. Another key word is neutral loss. This is pivotal in acquiring MS3 
in DDA-MS phosphoproteomics: the spectra are continuously monitored for the fixed loss of 
phosphate group. 
 
4: Purpose and objectives 
The purpose of my work was to compare the phosphoproteomes of chronologically aging yeast 
Saccharomyces cerevisiae, using quantitative mass spectrometry. The purpose was met through a 
series of experiments. Yeast cultures were grown and studied under dietary caloric restriction 
(CR) (versus not restricted (non-CR)) in the context of quiescence (Q) (versus non-quiescence 
(NQ)) comparing wild-type (WT) and tor1 deletion mutant. Wild-type phosphoproteomes have 
been done in duplicate, while mutant phosphoproteome duplicate is to be carried out in the future 
by members of the lab. For WT, all four possible populations have been studied:  CR-Q, CR-NQ, 
non-CR-Q, and non-CR-NQ. For the mutant, non-CR-NQ were nonexistent (please see chapter 
IV for details). For studying chronological aging, the yeast populations were harvested at 
different stages of culture growth (for five time points for each population). 
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By studying the phosphoproteome of each population, I gathered data about the phosphorylation 
state of proteins, discovered novel phosphorylation sites, confirmed known phosphorylation 
sites, and summarized kinases involved in the phosphorylation of above-mentioned 
phosphoproteins. By studying the phosphoproteomes of WT S. cerevisiae, I inferred how caloric 
restriction delays chronological aging. By comparing WT with TOR1-deficient mutant, I made 
inferences about the importance of TOR1 (notable as part of TOR1 protein complex, TORC1; a 
pro-aging kinase) in entrance into quiescence, maintenance of quiescence, and exit from 
quiescence under CR and non-CR conditions. I explored how TORC1 inactivity contributed to 




CHAPTER II: MATERIALS AND METHODS 
 
1.0: Note about water used 
All water coming in contact with proteomics samples and equipment (that contacted samples) 
was fresh MilliQ pure water only. Tap and distilled water were only used for washing and 
rinsing the dishes, and relevant equipment was rinsed with fresh MilliQ water. Proteomic 
samples are those that would eventually come in contact with the mass spectrometer (i.e. not 
including culture samples taken for counting and plating; sterile water was used in those 
instances). 
 
1.1: Yeast strains and growth conditions 
Wild-type (WT) Saccharomyces cerevisiae. Culture grown in YEP (1% yeast extract, 2% 
peptone) liquid medium, with either 0.2% glucose, or 2% glucose. Medium volume / flask 
volume (Erlenmeyer flask) is 1:5. Culturing at 200 rpm constant rotational shaking, at 30°C.  
Identical growth conditions for tor1 deletion mutant Saccharomyces cerevisiae. 
 
Table 1. Saccharomyces cerevisiae strains used 
Strain name Strain ID Genotype Source 
Wild-type (WT) BY4742 MATα his3-∆1 leu2-∆0 lys2-∆0 ura3-∆0 Thermo Fisher 
Scientific  
Tor1 deletion mutant BY4742 
tor1∆ 





2: Separation of quiescent and non-quiescent cell populations by Percoll density gradient 
centrifugation 
Mixing by pipetting 2 mL 1.5 M NaCl with 16 mL Percoll beads solution, in a 50 mL conical 
centrifuge Falcon tube. 4 mL of the Percoll-NaCl solution was transferred into  4 pollyallomer 
tubes for MLS-50 rotor [Beckman Coulter, Inc]; 4mL of Percoll-NaCl forms the density 
gradient. The 4 tubes were centrifuged at 25,000 × g (16,000 rpm) for 15 minutes at 4°C in 
MLS-50 rotor in Optima MAX ultracentrifuge [Beckman Coulter, Inc]. Sample of yeast cells 





 cells were pelleted by centrifugation in conical centrifugation Falcon tubes at 
3,400 rpm at room temperature in IEC Centra CL2 tabletop clinical centrifuge. Pelleted cells 
were gently resuspended in 500 µL of 50 mM Tris/HCl buffer (pH 7.5). The resuspended cells 
were overlaid on the prepared Percoll-NaCl gradient, and centrifuged at 5,000 rpm for 30 
minutes at 25°C in an Optima MAX ultracentrifuge. The upper (low density) and lower (higher 
density) fractions of cell population were collected with a pipette, in separate 15 mL Falcon 
tubes, combining all similar fractions (low with low, high with high) from the same sample. 
Cells were washed twice with 50 mM Tris/HCl buffer (pH 7.5), and subsequently resuspended in 
the same buffer for storage (-80°C).  
 
3: Protein preparation for digestion 
3.1: Glass bead lysate 
Cell sample was lysed using glass beads as follows. Cells were pelleted by centrifugation at 
3,000 rpm for 60 seconds at room temperature in the Centra CL2 tabletop clinical centrifuge. 
The pellet was then gently resuspended in 500 uL of 2% CHAPS in 25 mM Tris/HCl buffer (pH 
8.5) at RT. Resuspended cells were pelleted by centrifuging at 16,000 rcf for 15 seconds at RT, 
and the supernatant removed (1
st
 wash). A second wash was done in the same manner. The 
resulting pellet was resuspend  in 1 mL of ice-cold 2% CHAPS in 25 mM Tris/HCl buffer (pH 
8.5). Glass beads [SIGMA-ALDRICH] (about 250 uL; depending on cell volume initially used) 
were added to the sample. Samples were then vigorously shaken using a disrupter (courtesy of 
Brett lab) at 4°C. 
Glass beads and cell debris were then pelleted by centrifugation at 16,000 rcf for 5 minutes at 
4°C.  
Immediately after centrifugation, supernatant of the glass bed lysate was transferred into a pre-
chilled Eppendorf tube.  
To measure protein concentration, Bradford assay followed before proceeding to protein 
precipitation. 
 
3.2: Bradford protein assay 
A standard curve was prepared using bovine serum albumin (BSA) in water. Bradford Reagent 
(BR) was diluted to 1X in water. Samples were added to 1 mL of Bradford Reagent, mixed by 
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vortexing (in an Eppendorf tube), and incubated for 10 minutes at room temperature. 30 seconds 
before the 10 minutes incubation end, the sample was pipetted into a clear, plastic cuvette, and 
inserted into the spectrophotometer*. Absorbance at 595 nm was read (blank = 1X BR). 
*Technical note about spectrophotometers: Due to the early demise of our grand 
spectrophotometer, Beckman Coulter spectrophotometer DU 800, I have temporarily used the 
Nanodrop 2000C [courtesy of Brett lab], until out new, beloved spectrophotometer arrived: 
BioMate 160 by Thermo Scientific. Therefore, not all experiments – while all samples within a 
given experiment – were read using the same spectrophotometer.  
 
3.3: Protein precipitation 
For phosphoproteomics, 200 μg of proteins was taken for each sample. To the required sample 
volume (for 200 μg of proteins), TCA (dissolved in water prior to addition) was added to a final 
concentration of TCA as 10%. Sample with TCA was vortexed and incubated on ice for 30 
minutes, for precipitation. The cold sample was then centrifuged at 16, 000 x g for 10 minutes at 
4°C. The supernatant was discarded. The compact pellet was washed with 80% ice-cold acetone 
by adding 1.4 mL of 80% acetone, incubating on ice for 15 minutes, and centrifuging at 16, 000 
x g for 10 minutes at 4°C. Acetone discarded. This wash was done twice. To completely 




To the dry pellet protein samples, SDS-PAGE sample buffer* is added: 193.4 μL of sample 
buffer with 6.6 μL of 2M Tris, for a protein concentration of 1 μg/μL. The pellet is resuspended 
in the denaturing sample buffer, and incubated overnight at RT. Samples were loaded on SDS-
polyacrylamide gels (please see specifications below). Samples were run at 200V (constant) no 
more than 15 minutes: allowing all proteins to enter the running gel, while avoiding thorough 
separation (please see protein extraction). The gels were fixed with fixing solution (40% ethanol 
with 10% acetic acid), for 15 minutes on shaker at 55 rpm in clear plastic dishes with lids). After 
thorough rinsing with water, gels were stained with QC Colloidal Coomassie Blue for 1 hour on 
shaker at 55 rpm. Then, gels were destained with water for 4 15 minute intervals changing water 




 *The SDS-PAGE sample buffer is 2 % SDS, 10 % Glycerol, 5 % β-mercaptoethanol, 
0.005% bromophenol blue in 62.5 mM Tris/HCl (pH 6.8). 
 Running gel: 12.5% acrylamide/bis-acrylamide with 1% SDS in 0.375 M Tris/HCl 
(pH8.8). 
 Stacking gel 4% acrylamide/bis-acrylamide with 1% SDSin 0.125M Tris/HCl (pH 6.8) . 
 Electrode buffer: 0.1% SDS, 0.3 %, 1.44% glycine (final pH 8.3; no adjustment 
required). 
 
4: Protein digestion and peptide extraction  
Protocol courtesy of CBAMS – rewritten for thesis. 
Protein samples in SDS-polyacrylamide gels were excised from gels into pieces of 
approximately 1x1x0.5 mm and placed into 1.5 mL Eppendorf tubes. Samples were reduced 
using 50 mM NH4HCO3 (Ammonium bicarbonate = ABC) with 10mM DL-Dithiothreitol (DTT) 
for 30 minutes. Solution discarded. Samples were then alkylated using 50 mM iodoacetamide in 
50 mM ABC, away from light. Solution was discarded. Samples were then subjected to a series 
of washes with increasing acetonitrile (ACN) concentrations – all at RT. 1
st
 wash using 50 mM 
ABC for 15 minutes. 2
nd
 wash using 25 mM ABC with 5% ACN for 15 minutes. 3
rd
  and 4
th
 
washes using 25mM ABC with 50% ACN for 30 minutes each. 5
th
 wash using 100% ACN for 
10 minutes. To completely remove ACN, gel pieces were dried in SpeedVac for 8 minutes (at 
43°C). 
The dried gel pieces were rehydrated with a 0.01 μg/μL trypsin in 25mM ABC solution (with a 
1:20 trypsin to proteins ratio). Digestion was incubated overnight at 30°C.  
The peptides (i.e. the digested sample proteins in gel pieces) were extracted using extraction 
solution (volume = 4 volumes of trypsin solution used): 60% ACN with 0.5% formic acid. To 
extract, the extraction solution is added to sample, vortexed, incubated for 15 minutes at room 
temperature and collected. There were3 extractions (collecting each round into the same 1.5 mL 
Eppendorf tube). Peptide samples were dried in SpeedVac for several hours. 





5: Phosphopeptides enrichment by TiO2  
Protocol courtesy of GE Healthcare Life Sciences (beads manufacturer; instructions 28-9537-65 
AB) – rewritten for thesis. 
Sample peptides are resuspended in a total volume of 250 μL of binding buffer (1M glycolic acid 
in 80% acetonitrile with 5% trifluoroacetic acid). Titanium dioxide (TiO2) magnetic beads slurry 
(50 μL handled with cut pipette tips) was equilibrated by removing storage solution and washing 
with binding buffer (no incubation). Sample was then applied to beads, resuspended, and 
incubated with 360 rotation for 30 minutes. The buffer was removed. The beads were washed 
once using 500 μL of binding buffer, and then washed twice using 500 μL of wash buffer (80% 
ACN with 1% TFA). Sample was then eluted from the beads using elution buffer (5% 
ammonium hydroxide, pH12): adding 50 μL of elution buffer, incubating for 5 minutes, and 
collecting the eluate. Elutes for a total of 100 uμ (i.e. twice), combining the eluates. 
 Notes: When working with the magnetic beads, using the MagRack 6, applied solutions 
without magnet and removed solutions (with pipette) with magnet; resuspending solutions by 
manual inversion. Incubating sample with beads using a 360 rotation rack at RT. 
 
6: Mass spectrometry 
To prepare sample peptides for mass spectrometry, samples were dried in SpeedVac. The dry 
peptide pellets were reconstituted in 2% acetonitrile with 1% formic acid, to inject 200 ng in 5 
μL (injection volume). The method used is reverse-phase high performance liquid 
chromatography coupled to tandem mass spectrometry (RP-HPLC-MS/MS) using EASY-nLC™ 
II coupled to LTQ Orbitrap Velos (nanospray ion source; MS1 resolution of 60 000). Column 
used is 10 cm by 100 µm C18 packed in-house. For this label-free identification of 
phosphopeptides, used neutral-loss induced MS3, with multistage activation. The total run time 
was 92 minutes, with 90 minutes gradient (from 3% acetonitrile with 0.1% formic acid to 97% 
acetonitrile with 0.1% formic acid) with a constant sample elution of 400 nL per minute.  
 
7. Software 
Thermo Proteome Discoverer 2.2.0.388 and SEQUEST were used to search Saccharomyces 
cerevisiae databases (SwissProt TaxID=559292_and_subtaxonomies, v2017-10-25; TrEMBL 
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TaxID=559292, v2017-10-25), using custom workflows. Reported peptides and proteins have a 
set false discovery rate < 1%.  
Proteome Discoverer 2.2.0.388 (PD2.2) was also used to generate several figures. Microsoft 
Office was used to process the data exported (or extrapolated) from PD2.2 for data presentation 
purposes. Helper computer applications (such as Microsoft Windows Paint) were also used to 
present data. Microsoft Office Word was used in writing of this thesis – converted to PDF/A 




CHAPTER III: PHOSPHOPROTEOMES OF CHRONOLOGICALLY AGING WILD-
TYPE YEAST 
 
Note: High density cells (HD; in Percoll gradient) are mainly quiescent (Q) while low density 
cells (LD; in Percoll gradient) are mainly non-quiescent (NQ) (Leonov et al. 2017). As such, I 
used HD/LD in annotation of data (to avoid bias in case of reassessment of data). Nonetheless, I 
use HD/Q and LD/NQ interchangeably in chapters III and IV). 
 
1. Hypothesis  
Considering that reversible protein phosphorylation regulates many (if not all) biological 
processes, it is plausible that this type of post-translational protein modification is used to 
regulate the biological processes required to maintain the state of quiescence and the responses 
of quiescent and non-quiescent cells to caloric restriction. Therefore, the phosphoproteomes of 
WT yeast were expected to be significantly different between CR-HD and CR-LD, non-CR-HD 
and non-CR-LD, as well as between CR-HD and non-CR-HD, and CR-LD and non-CR-LD; 
assuming that HD are primarily quiescent and that LD are mainly non-quiescent.  
 
2. Results and Discussion   
 
I found hundreds of phosphorylated proteins in samples recovered at each of the five days of 
collection (days 0, 1, 2, 5, and 7). The tables below (Tables 2.1 – 2.5) outline the number of 
phosphoproteins and peptide spectrum matches (PSMs) in chronological order where day 0 
represents the first day after mid-exponential growth. Since the WT data was done in duplicate, 
data for both experiments (experiments 1 and 2 in Tables 2.1-2.5) is provided. Please see 
supplemental figures for relative sample abundances across these experiments; all sample 
abundances were similar (Figures S6A-B for experiment 1, and Figures S7A-B for experiment 
2). The peptide spectrum matches are the number of detected peptides contributing to 
identification of proteins. The number of PSMs, however, is not the number of peptides 
identified; some peptides, for example, may contribute to the identification of several proteins 
(such as peptides that are common among a protein family). The PSMs were filtered to only very 
high confidence peptides (meaning that less than 1 % of the identified peptides from spectra are 
due to false discovery). Some peptides may be identified multiple times, if they are present in 
multiples in the sample. Less abundant peptides are nevertheless captured by the mass 
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spectrometer. When such low abundance fragments do not meet the stringent qualification, they 
are not used in assignment to identify proteins. This, therefore, leads to missed identification of 
very low abundance proteins. In the context of label-free experiment, this can be remedied to 
some extend by making large studies that combine all relevant samples plus a pooled sample for 
the analysis. One of the benefits is identifying more proteins. Since the system is given more 
spectra to analyze; by aligning peptide retention times, for example, the software (I used Thermo 
Proteome Discoverer 2.2.0.388 and SEQUEST) can increase the confidence of assigning spectra 
to peptide and therefore have more peptides to match to proteins thus possibly leading to more 
proteins detected. 
The repeat of the experiment of studying the effects of caloric restriction on quiescent and non-
quiescent WT yeast cells yielded less phosphoproteins. I believe that the main contributing factor 
was using a different batch of titanium dioxide beads. It is inevitable to use different batches, due 
to the shelf life of the beads. I have no claims to the manufacturer, however. I also used a 
different batch of trypsin for each experiment. This did not have a significant effect, happily, as 
can be seen from the low missed cleavages by trypsin (i.e. high zero missed cleavages): 45.48% 
no missed cleavage, 37.14% 1 missed cleavage, and 17.37% 2 missed cleavages in experiment 1 
(with higher phosphoprotein count post analysis) and 50.99% no missed cleavage, 36.14% 1 
missed cleavage, and 12.87% 2 missed cleavages in experiment 2 (with lower phosphoprotein 
count) (please see supplemental figure S9 for experiment 1, and S10 for experiment 2 missed 
cleavage percentages). The cleavage sites are predicted by the software and compared to sample. 
 









1 7621 647 
2 2819 115 
HD 
1 7759 695 
2 4197 373 
non-CR 
LD 
1 7772 668 
2 4788 439 
HD 
1 9170 802 















1 6963 611 
2 3491 295 
HD 
1 6319 524 
2 6970 502 
non-CR 
LD 
1 7448 662 
2 5183 409 
HD 
1 9200 788 
2 2991 308 
 









1 7559 644 
2 2286 245 
HD 
1 8126 701 
2 5602 505 
non-CR 
LD 
1 6029 553 
2 2477 291 
HD 
1 7045 589 
2 2748 297 
 









1 6688 530 
2 2055 230 
HD 
1 8899 528 
2 3621 349 
non-CR 
LD 
1 5626 392 
2 5536 536 
HD 
1 9872 756 


















1 7943 658 
2 3680 360 
HD 
1 8913 329 
2 4836 410 
non-CR 
LD 
1 6412 482 
2 8158 449 
HD 
1 9873 761 
2 4665 226 
 
Following the general assessment of total phosphorylated proteins identified, principal 
component analysis (PCA) was done on the samples to see if diet and/or density had the 
expected effect of qualifying the samples as significantly different. The PCA using 
phosphoproteins is seen in Figure 1 (The data shown is from experiment one as seen in Tables 
2.1-2.5). The first principal component (PC) accounts for 21.5% of the variability in the data, and 
the second PC for 17.5%. The principal components were drawn, by the software, from spectra. 
A pool sample was used to better the quantization; note that the pool sample is not necessarily a 
pool of the samples for the given experiment. Rather, the pool is a mixture of different 
phosphopeptide samples from another experiment – this explains why the pool sample is not 
necessarily at the center of the PCA plot. Figure 1A highlights samples based on their diet only. 
There is indeed a difference between the samples based on the diet alone. CR are samples 
initially grown on 0.2% glucose in YEP medium, while non-CR are cultures grown initially on 
2% glucose in YEP medium (please see chapter II). Figure 1B presents the same PCA but with 
only the density being made evident. It may seem that the samples have no clear trend, but that is 
explained by Figure 1C. Indeed, Figure 1C shows both diet and density of the samples. The 
pattern is: samples are more similar based on their diet (across densities) than by their densities 
(across diets). CR-HD are more similar to CR-LD than to non-CR-HD: quiescent cells from 
different diets have significantly different phosphoproteomes. Comparatively, CR-LD are more 
similar to CR-HD than to non-CR-LD: non-quiescent cells from different are also dramatically 
different from each other. In conclusion, quiescent (HD) cells are more different from each other 
(CR-HD vs. non-CR-HD) than are non-quiescent (LD) cells across diets. Figure 1D identifies all 
the samples. In Figure 1D, closer to the center of the plot, two overlapping samples are seen: 
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non-CR D5 LD and CR D7 LD – where D stands for day. Also close to them are populations D7 
non-CR LD and arguably D5 CR LD. These cultures come from different diets of chronological 
old WT cells. Their common feature is the low density. So, these chronologically old, non-
quiescent cells have similar phosphoproteomes. That is most likely because these non-quiescent 
cells are converging on senescence and death. Their quiescent counterparts (for both CR and 
non-CR, days 5 and 7) are far removed from them: day 5 are in upper left quadrant while day 7 
are in the upper right quadrant. While the samples of the same diet are close to each other, the 
samples of the same age of different diets are far removed. This indicates that these WT 
quiescent populations age in similar ways for a given diet (CR or non-CR). 
 
Figure 1. Principal component analysis of phosphorylated proteins found in WT S. cerevisiae 
under CR/non-CR with different population densities, at different chronological ages 
 























D. All samples identification 
 
 
Given the trends from the PCA across time, I looked at each time point separately: comparing 
different populations of the same chronological age. The difference between the 
phosphoproteomes is quantified by the number of unique phosphoproteins – proteins that are 
found in one sample but not in its comparable counterpart and vice versa. In fact, this was 
observed, as seen in Figures 1.1-1.5 of such unique phosphoproteins in chronological age of 
yeast. (Please note, only one repeat is shown in Figures 1.1-1.5; this is data from experiment 1.) 
Figures 1.1-1.5 are in chronological age of samples (Figure 1.1 – day 0, Figure 1.2 – day 1, 
Figure 1.3 – day 2, Figure 1.4 – day 5, Figure 1.5 – day 7). Within each of these figures, I show 
the number of unique and shared phosphoproteins. Figures A compare CR-HD to CR-LD (CR 
diet, different densities), Figures B compare non-CR-HD to non-CR-LD (non-CR diet, different 
densities), Figures C compare CR-HD to non-CR-HD (different diets, high density), and Figures 
D compare CR-LD to non-CR-LD (different diets, low density). There is generally about a 
thousand (lowest 807 in Figure 1.4D, and 1091 highest in 1.2B) shared phosphorylated proteins. 
This is expected and generally represents housekeeping proteins that are required in the 
phosphorylated state. A caveat of this quantization is that some of the shared proteins may have a 
different phosphorylation state – different phosphosites – detected. Among the unique 
phosphoproteins, however, there is no question: they are either found or not found in qualifying 
amounts. There are generally a few dozen (lowest: 13 seen in Figure 1.4B) to over a hundred 
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(highest: 255 in 1.5C) of such proteins. These phosphoproteins agree that the phosphoproteomes 
of each sample is its unique signature given the diet, density, and age. 
 




























Found in Samples: [S1] F1: ฀฀Sample, CR, D0, HD 
42
Found in Samples: [S2] F2: ฀฀Samp     
33
1006
Colour Exclusive Total Found in sample
   42 1048 CR, D0, HD
   33 1039 CR, D0, LD
   1006 1006 CR, D0, HD and CR, D0, LD
Sum 1081
Found in Samples: [S3] F3: ฀฀Sample, non CR, D0, HD 
70
Found in Samples: [S4] F4: ฀฀Sample      
33
1085
Colour Exclusive Total Found in sample
   70 1155 non-CR, D0, HD
   33 1118 non-CR, D0, LD
   1085 1085 non-CR, D0, HD and non-CR, D0, LD
Sum 1188
Found in Samples: [S1] F1: ฀฀Sample, CR, D0, HD 
36
Found in Samples: [S3] F3: ฀฀Sample      
143
1012
Colour Exclusive Total Found in sample
   36 1048 CR, D0, HD
   143 1155 non-CR, D0, HD
   1012 1012 CR, D0, HD and non-CR, D0, HD
Sum 1191
Found in Samples: [S2] F2: ฀฀Sample, CR, D0, LD 
27
Found in Samples: [S4] F4: ฀฀Sample      
106
1012
Colour Exclusive Total Found in sample
   27 1039 CR, D0, LD
   106 1118 non-CR, D0, LD































Found in Samples: [S5] F5: ฀฀Sample, CR, D1, HD 
64
Found in Samples: [S6] F6: ฀฀Sample     
139
908
Colour Exclusive Total Found in sample
   64 972 CR, D1, HD
   139 1047 CR, D1, LD
   908 908 CR, D1, HD and CR, D1, LD
Sum 1111
Found in Samples: [S8] F8: ฀฀Sample, non CR, D1, HD 
52
Found in Samples: [S7] F7: ฀฀Sample      
46
1091
Colour Exclusive Total Found in sample
   52 1143 non-CR, D1, HD
   46 1137 non-CR, D1, LD
   1091 1091 non-CR, D1, HD and non-CR, D1, LD
Sum 1189
Found in Samples: [S5] F5: ฀฀Sample, CR, D1, HD 
34
Found in Samples: [S8] F8: ฀฀Sample      
205
938
Colour Exclusive Total Found in sample
   34 972 CR, D1, HD
   205 1143 non-CR, D1, HD
   938 938 CR, D1, HD and non-CR, D1, HD
Sum 1177
Found in Samples: [S6] F6: ฀฀Sample, CR, D1, LD 
39
Found in Samples: [S7] F7: ฀฀Sample      
129
1008
Colour Exclusive Total Found in sample
   39 1047 CR, D1, LD
   129 1137 non-CR, D1, LD
   1008 1008 CR, D1, LD and non-CR, D1, LD
Sum 1176
Found in Samples: [S9] F9: ฀฀Sample, CR, D2, HD 
37
Found in Samples: [S10] ฀฀F10: Sam     
75
1038
Colour Exclusive Total Found in sample
   37 1075 CR, D2, HD
   75 1113 CR, D2, LD
   1038 1038 CR, D2, HD and CR, D2, LD
Sum 1150
Found in Samples: [S11] ฀฀F11: Sample, non CR, D2, ฀฀HD 
40
Found in Samples: [S12] ฀฀F12: Sam      
116
986
Colour Exclusive Total Found in sample
   40 1026 non-CR, D2, HD
   116 1102 non-CR, D2, LD

































Found in Samples: [S9] F9: ฀฀Sample, CR, D2, HD 
108
Found in Samples: [S11] ฀฀F11: Sam      
59
967
Colour Exclusive Total Found in sample
   108 1075 CR, D2, HD
   59 1026 non-CR, D2, HD
   967 967 CR, D2, HD and non-CR, D2, HD
Sum 1134
Found in Samples: [S10] ฀฀F10: Sample, CR, D2, LD 
59
Found in Samples: [S12] ฀฀F12: Sam      
48
1054
Colour Exclusive Total Found in sample
   59 1113 CR, D2, LD
   48 1102 non-CR, D2, LD
   1054 1054 CR, D2, LD and non-CR, D2, LD
Sum 1161
Found in Samples: [S13] ฀฀F13: Sample, CR, D5, HD 
42
Found in Samples: [S14] ฀฀F14: Sam     
104
957
Colour Exclusive Total Found in sample
   42 999 CR, D5, HD
   104 1061 CR, D5, LD
   957 957 CR, D5, HD and CR, D5, LD
Sum 1103
Found in Samples: [S15] ฀฀F15: Sample, non CR, D5, ฀฀HD 320 Found in Samples: [S16] ฀฀F16: Sam      
13
851
Colour Exclusive Total Found in sample
   320 1171 non-CR, D5, HD
   13 864 non-CR, D5, LD
   851 851 non-CR, D5, HD and non-CR, D5, LD
Sum 1184
Found in Samples: [S13] ฀฀F13: Sample, CR, D5, HD 
18
Found in Samples: [S15] ฀฀F15: Sam      
190
981
Colour Exclusive Total Found in sample
   18 999 CR, D5, HD
   190 1171 non-CR, D5, HD
   981 981 CR, D5, HD and non-CR, D5, HD
Sum 1189
Found in Samples: [S14] ฀฀F14: Sample, CR, D5, LD 254
Found in Samples: [S16] ฀฀F16: Sam      
57
807
Colour Exclusive Total Found in sample
   254 1061 CR, D5, LD
   57 864  non-CR, D5, LD






















Among all the phosphorylated proteins (not exclusively the unique proteins discussed above), 
most of the found phosphoproteins localized to cytoplasm/cytosol, nucleus, and membranes (as 
can be seen from supplemental Figures S1-S5). The localization assignment was seen through 
the Proteome Discoverer and SEQUEST software, which relies on UniProt as the source 
database (please see methods), since that is the database I used in my workflows. It is possible to 
use other databases, but UniProt has the most numerous, reliable proteomics data for 
Saccharomyces cerevisiae. The nuance with the assignment of protein localization is two-folded. 
For one, the database provides all the possible subcellular localizations of the protein in all 
possible states of the cell and of the protein. So it is not necessarily the phosphorylated form of 
the protein that is found at these localizations. For example, a hypothetical protein with a 
phosphorylated serine was identified, and for this protein there are two localizations defined by 
Found in Samples: [S17] ฀฀F17: Sample, CR, D7, HD 
39
Found in Samples: [S18] ฀฀F18: Sam     
202
873
Colour Exclusive Total Found in sample
   39 912 CR, D7, HD
   202 1075 CR, D7, LD
   873 873 CR, D7, HD and CR, D7, LD
Sum 1114
Found in Samples: [S19] ฀฀F19: Sample, non CR, D7, ฀฀HD 
177
Found in Samples: [S20] ฀฀F20: Sam      
22
971
Colour Exclusive Total Found in sample
   177 1148 non-CR, D7, HD
   22 993 non-CR, D7, LD
   971 971 non-CR, D7, HD and non-CR, D7, LD
Sum 1170
Found in Samples: [S17] ฀฀F17: Sample, CR, D7, HD 
19
Found in Samples: [S19] ฀฀F19: Sam      
255
893
Colour Exclusive Total Found in sample
   19 912 CR, D7, HD
   255 1148 non-CR, D7, HD
   893 893 CR, D7, HD and non-CR, D7, HD
Sum 1167
Found in Samples: [S18] ฀฀F18: Sample, CR, D7, LD 
136
Found in Samples: [S20] ฀฀F20: Sam      
54
939
Colour Exclusive Total Found in sample
   136 1075 CR, D7, LD
   54 993 non-CR, D7, LD




the database: one in a non-phosphorylated state in the nucleus, and another in the cytoplasm 
when tyrosine (not identified in study) is phosphorylated. So, I count this protein as contributing 
to both the nuclear and cytoplasmic proteins identified, while its true localization at the time of 
collection is speculative. Moreover, many of the found phosphosites in the experiment are novel 
(not described in literature before, at least not in the major databases of UniProt and BioGrid; 
lists not shown in this thesis). For two, a single protein may have more than one subcellular 
localization assigned to it. In fact, proteins – be they phosphorylated or not – are known to be 
able to translocate (by different mechanisms). Therefore, the quantization of subcellular 
localization among the phosphorylated proteins identified is a trend more than concrete values, 
since it is not known where the protein was at the time of collection. Elaborate experiments on 
protein localizations (such as visualization under the microscope by using fluorescent tags on 
proteins of interest) would be required to assign protein localization with certitude. Nevertheless, 
I considered the trends of such localization. The majority of the phosphorylated proteins was 
found in cytoplasm/cytosol. This is expected of phosphorylated proteins that may be involved in 
signaling pathways. In fact, protein phosphorylation is one of the post-translational modifications 
that allows for protein subcellular relocalization. Moreover, phosphorylation also has a role in 
signaling that alters expression such as by the phosphorylation of transcription factors. Thus, 
detecting many proteins that may be localized in the nucleus is also plausible. Detecting 
numerous proteins that may localize to membranes indicates that many proteins may be tethered 
to a membrane (any membrane). Somewhat lesser, but still weighty part of the 
phosphoproteomes may also localize to the mitochondria. Since the mitochondria are signaling 
hubs, such localization is plausible.  
Additionally, novel phosphorylation sites have been identified (not shown in this thesis). 
 
Overall, the hypothesis was correct in that the yeast populations of different quiescent state under 
the same diets are different from each other, and that populations under different diets (but the 
same state of quiescence) are also different from each other. Furthermore, diet and density 
(indicative of the quiescence/not of the cells) were consistent trends for the WT cultures. 
Additionally, localization of phosphoproteins of interest suggested that phosphorylation 
identified might be from cell signaling pathways. Finally, the approach of looking at the 
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phosphoproteomes of WT yeast under calorie restriction (or no restriction) in the context of 










Considering that TOR1 is one of the major protein kinases known to phosphorylate many 
proteins implicated in various cellular processes, it is plausible that this nutrient-sensing protein 
kinase is involved in the phosphorylation of many proteins essential for the response of quiescent 
and non-quiescent yeast cells to caloric restriction. Thus, it was expected that the 
phosphorylation patterns of quiescent and/or non-quiescent cells carrying the tor1 mutation 
differ based on the culture diet and/or state of quiescence. It was also expected to find novel 
phosphorylation sites from the cultures lacking TOR1. 
 
2. Results and Discussion  
I identified hundreds of proteins in tor1 deletion mutant yeast populations, initially grown under 
caloric restriction or not calorically restricted conditions (Tables 3.1 shows the number of 
identified phosphoproteins, in chronological order). The TOR1 protein, as part of the TORC1 
complex, responds to nutrient levels. Under high nutrient (such as initially abundant glucose in 
YEP medium; non-CR), TORC1 can promote anabolic pathways such as ribosomal synthesis. 
Restricting TORC1 activity leads to chronological lifespan increase (please see introduction), 
such as when growing in glucose-poor conditions (CR) or cell not having TOR1 protein. 
Therefore, the phosphoproteomes of cells grown under conditions that inhibit TORC1 (TOR1 
being at the core) activity are expected to be similar to phosphoproteomes of cells with tor1 gene 
deletion. Moreover, WT-CR (HD and LD) are expected to be similar to tor1 mutant under CR 
(HD and LD). Under non-CR, the WT (with TOR1 functioning normally) and the tor1 mutant 
phosphoproteomes are expected to be significantly different, because of the protein kinase 
activity of TORC1. 
Furthermore, there were very low to no LD cells in non-CR. (Reminder: high density (HD) 
population is mainly quiescent (Q) cells, while low density (LD) population is mainly non-
quiescent (NQ) cells.) This indicates that yeast lacking TOR1 and initially grown under high 
calorie condition mostly differentiate into quiescent (HD) cells. For all samples, hundreds of 




Table 3.1. Phosphorylated proteins found in tor1 deletion Saccharomyces cerevisiae 
Day 
Diet band 






LD 1961 209 
HD 2165 277 
non-
CR 
HD 4291 478 
1 
CR 
LD 4394 406 
HD 6914 580 
non-
CR 
HD 3735 440 
2 
CR 
LD 4144 445 
HD 5086 494 
non-
CR 
HD 8072 731 
5 
CR 
LD 4158 400 
HD 4774 502 
non-
CR 
HD 4675 495 
7 
CR 
LD 4015 378 
HD 4916 385 
non-
CR 
HD 4911 505 
 
The protein-level principal component analysis (PCA) was done to assess the differences 
between the phosphoproteomes of the tor1 mutants and can be seen in Figure 2. Figure 2A 
highlights the differences in the samples based on their diet (CR – initially grown on 0.2% 
glucose in YEP, and non-CR – initially grown on 2% glucose in YEP). There is a significant 
difference, as the non-CR samples are consistently distinguishable from CR samples on both the 
first (which accounts for a total of 25.5% of variability in the data) and second (which accounts 
for a total of 17.5%) principal components. In Figure 2B, with the density as the label, the 
pattern is not as clear. This is clarified by 2C whence both diet and density are labeled. The non-
CR-HD (no LD under this diet – please see above) are different from the CR-HD and CR-LD 
samples, while CR-HD and CR-LD are comparatively more similar to each other. Figure 2D 
shows all the labels of samples. A pattern is seen for the CR samples: for the same age, the 
samples are more distinguished based on PC1 than on PC2. These patterns can be seen more 
clearly in Figure 2E with only the CR samples shown. For days 2 and 7 the CR samples (see line 
3 and 5 respectively in figure 2E) exhibit pattern with CR-LD having a lower PC1 value than 
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CR-HD, while all other sample have HD with a lower PC1 value than LD. Among the CR 
samples, there is clear distinction between HD and LD populations. The least variation is in the 
oldest populations, at day 7, with about 11.5% on PC1 and 0.5% on PC2 (line 5 in Figure 2E). 
The variation is consistently larger in younger populations. To the first decimal, the approximate 
distance between the points in the given PC1 (29.5%) and PC2 (19.4%) plot are 11.5% at day 7 
(line 5), 27% at day 5 (line 4), 33% at day 2 (line 3), 40.7% at day 1 (line 2), and 31.8% at day 0 
(line 1). Only day 0, the youngest population, stands out. This is most likely because at day 0 the 
culture is not yet at the diauxic stage (like day 1 would be; day 5 would be post-diauxic, and day 
7 stationary). Many early commitment proteins are therefore expected to be expressed and 
phosphorylated – the very proteins that may help in the entry into quiescence, for example. At 
later age, the programs of quiescence maintenance are in effect. So, the phosphoproteomes are 
still significantly different (for the given age and culture, at different densities), but are less 
different from each other as they age together.  
 
 
Figure 2. Principal component analysis of phosphorylated proteins found in tor1 deletion mutant 
S. cerevisiae under CR/non-CR with different population densities, at different chronological 
ages 




B. Emphasis on density 
 












D. All samples identification 
 











Among the identified phosphoproteins, I not only looked at the patterns (please see above), but 
also at the phosphorylation sites for unique phosphoproteins. The list of some of the 
phosphosites can be found in supplemental Tables S1-S10. When setting up the studies of 
samples within an experiment (such at all tor1 gene deletion mutants), I processed the samples 
together with the addition of the pooled sample. As discussed in the previous chapter, I used a 
pool sample which allows for higher identification of peptides and therefore possible higher 
number of proteins. However, in the current set up of the software, I cannot assign the 
phosphosite (Psite) to the respective sample in was found in. In other words, I tradeoff the Psite 
source for identify more proteins by making a large study. Therefore, by looking at individual 
studies (i.e. the spectra of a single sample against the database) I regain the Psite assignment. In 
the supplemental Table S1-S10, I provide the Psites found by making a study along with Psites 
identified from individual studies. Evidently, I do not find all of the phosphorylated proteins in 
the individual studies, and so some information is lacking (as seen in Table S10). Moreover, the 
number of phosphorylated proteins that are unique to a sample in contrast to its comparable 
sample (see Figures 2.1-2.5) does not match the number of phosphorylated proteins in the Tables 
S1-S10 (which is why these tables are provided as supplemental material and not as the core of 
my thesis). The main reason that these quantities do not add up is due to the stringency of 
selecting the present/not proteins. From the large study, the software analyses and includes 
samples that have peaks that are not intense (i.e. low relative abundance of peptide fragment). 
While making the lists in Tables S1-S10, I manually selected only proteins that are found in high 
amounts in one sample and not found in the other sample. To clarify: I did not include samples 
that have a peak found (but are not high abundance) when selecting unique phosphoproteins. For 
example, a theoretical protein X may have a peak found in sample 1, but no peak found in 
sample 2: the Venn diagram would include such protein X as unique to sample 1 (not present in 
sample 2). Manually, however, I do not include such a protein X, because it is not in high 
abundance in sample 1.  
As anticipated by the hypothesis, the populations (Q-CR, NQ-CR, and Q-non-CR) are different 
from each other. This can be seen by the number of unique phosphoproteins for the given sample 
pair comparison (as seen in Figures 2.1-2.5 in chronological order of the yeast culture). The 
relative abundance of all samples was uniform at the peptide level (Figure S8A), and at the 




























Found in Samples: [S2] ฀฀F2: Sample, CR, HD, D0 
151
Found in Sample Groups: ฀฀CR, LD   
19
622
Colour Exclusive Total Found in sample
   151 773 CR, HD, D0
   19 641 CR, LD, D0
   622 622 CR, HD, D0 and CR, LD, D0
Sum 792
Found in Samples: [S2] ฀฀F2: Sample, CR, HD, D0 
40
Found in Sample Groups: ฀฀non CR    
64
733
Colour Exclusive Total Found in sample
   40 773 CR, HD, D0
   64 797 non-CR, HD, D0
   733 733 CR, HD, D0 and non-CR, HD, D0
Sum 837
Found in Samples: [S5] ฀฀F5: Sample, CR, HD, D1 
91
Found in Sample Groups: ฀฀CR, LD   
15
768
Colour Exclusive Total Found in sample
   91 859 CR, HD, D1
   15 783 CR, LD, D1
   768 768 CR, HD, D1 and CR, LD, D1
Sum 874
Found in Samples: [S5] ฀฀F5: Sample, CR, HD, D1 
56
Found in Sample Groups: ฀฀non CR    
29
803
Colour Exclusive Total Found in sample
   56 859 CR, HD, D1
   29 832 non-CR, HD, D1
   803 803 CR, HD, D1 and non-CR, HD, D1
Sum 888
Found in Samples: [S8] ฀฀F8: Sample, CR, HD, D2 
27
Found in Sample Groups: ฀฀CR, LD   
36
810
Found in Samples: [S8] ฀฀F8: Sample, CR, HD, D2 
16




























The hypothesis regarding discovery of novel phosphosites in this mutant model was confirmed 
by looking at the phosphorylation of unique proteins. There are novel Psites in the shared (not 
unique) phosphoproteins also (not shown in this thesis). Tables S1 and S2, for day 0, include a 
protein kinase search of the online databases Uniprot (at www.uniprot.org) and BioGrid (at 
www.thebiogrid.org); this search was done manually, by looking at all the PTM described for the 
Colour Exclusive Total Found in sample
   27 837 CR, HD, D2
   36 846 CR, LD, D2
   810 810 CR, HD, D2 and CR, LD, D2
Sum 873
Colour Exclusive Total Found in sample
   16 837 CR, HD, D2
   100 921 non-CR, HD, D2
   821 821 CR, HD, D2 and: non-CR, HD, D2
Sum 937
Found in Samples: [S11] ฀฀F11: Sample, CR, HD, D5 
91
Found in Sample Groups: ฀฀CR, LD   
9
787
Colour Exclusive Total Found in sample
   91 878 CR, HD, D5
   9 796 CR, LD, D5
   787 787 CR, HD, D5 and CR, LD, D5
Sum 887
Found in Samples: [S11] ฀฀F11: Sample, CR, HD, D5 
51
Found in Sample Groups: ฀฀non CR    
25
827
Colour Exclusive Total Found in sample
   51 878 CR, HD, D5
   25 852 non-CR, HD, D5
   827 827 CR, HD, D5 and non-CR, HD, D5
Sum 903
Found in Samples: [S14] ฀฀F14: Sample, CR, HD, D7 
42
Found in Sample Groups: ฀฀CR, LD   
37
796
Colour Exclusive Total Found in sample
   42 838 CR, HD, D7
   37 833 CR, LD, D7
   796 796 CR, HD, D7 and CR, LD, D7
Sum 875
Found in Samples: [S14] ฀฀F14: Sample, CR, HD, D7 
29
Found in Sample Groups: ฀฀non CR    
59
809
Colour Exclusive Total Found in sample
   29 838 CR, HD, D7
   59 868 non-CR, HD, D7




given protein. For this young cell population, among its unique phosphoproteins can be seen 
SCH9 (P11792) that has known residues under the control of TOR1 kinase activity. The sample 
SCH9 was exclusively found in is day 0 – CR – HD: chronologically young quiescent cells 
initially grown under calorie restriction condition. Since the cells lack TOR1, I expect these 
phosphosites to not be phosphorylated, unless there is another protein kinase known (or 
suggested) to overlap in phosphorylation. The residues of SCH9 known to be phosphorylated by 
TOR1 are S711, T723, S726, T737, S758, and S765 (in red in Table S1). As expected, none of 
these residues were found phosphorylated. The Psites found in this mutant are S288, S289, and 
S290. All three of these phosphosites have been previously described in literature; yet, have no 
putative protein kinase responsible for these phosphorylation events. 
As mentioned before, many of the found phosphosites are novel. It is possible that they have 
been found previously be researchers. However, since there is no data available on the major 
databases (including UniProt, which has both manually curated and unverified, automatically 
assigned information), it can be said that these phosphosites are novel. An example of such 
Psites is found on uncharacterized membrane protein YDL218W (Q07629) with no known 
phosphosites. I found 15 novel phosphosites: T219, S220, S266, S272 Y279, S280, T281, S284, 
S288, Y289, T294, S299, S303, S305, T306 among which S272, S288, S303, S305, and T306 
are from sample of HD cells initially grown under CR and harvested at day 0 (these Psites may 
be found in other samples as well) (Table S1). I also found novel phosphosites for previously 
described proteins such as for the nucleoside diphosphate kinase (YNK1; P36010) which has a 
single known phosphosite at T95. I found phosphorylated residues T95 (known), T104, S121, 
and S123 (Table S1). This protein has no described putative protein kinase responsible.  
In conclusion, by studying tor1 gene deletion mutant, I found that, as expected, the samples 
different greatly based on their diet (initially under calorie restriction or not) and based on their 
state of quiescence (for cultures initially grown under caloric restriction). I found that the 
absence of TOR1 allowed cells initially grown under not calorically restricted conditions to be 
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Figure S1. Cellular localization of phosphoproteins found in WT Saccharomyces cerevisiae 
– day 0 
A. Phosphoproteins per sample
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Figure S2. Cellular localization of phosphoproteins found in WT Saccharomyces cerevisiae 
– day 1 
A. Phosphoproteins per sample 
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Figure S3. Cellular localization of phosphoproteins found in WT Saccharomyces cerevisiae 
– day 2 
A. Phosphoproteins per sample 
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Figure S4. Cellular localization of phosphoproteins found in WT Saccharomyces cerevisiae 
– day 5 
A. Phosphoproteins per sample 
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Figure S5. Cellular localization of phosphoproteins found in WT Saccharomyces cerevisiae 
– day 7 
A. Phosphoproteins per sample 
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Figure S9. Missed cleavage by trypsin – WT – experiment 1 
 
 








S11. Missed cleavage by trypsin –tor1∆ 
 
 
 
  













